K.O. Ellis

761 total citations
20 papers, 616 citations indexed

About

K.O. Ellis is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Organic Chemistry. According to data from OpenAlex, K.O. Ellis has authored 20 papers receiving a total of 616 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 6 papers in Cellular and Molecular Neuroscience and 5 papers in Organic Chemistry. Recurrent topics in K.O. Ellis's work include Ion channel regulation and function (5 papers), Synthesis of heterocyclic compounds (2 papers) and Neuroscience and Neuropharmacology Research (2 papers). K.O. Ellis is often cited by papers focused on Ion channel regulation and function (5 papers), Synthesis of heterocyclic compounds (2 papers) and Neuroscience and Neuropharmacology Research (2 papers). K.O. Ellis collaborates with scholars based in United States and United Kingdom. K.O. Ellis's co-authors include John F. Carpenter, S. H. Bryant, Robert P. Halliday, James L. Butterfield, Thomas J. Schwan, Robert L. White, John T. Watson, Alan Horner, Richard Milner and Stephanie Allen and has published in prestigious journals such as Journal of Medicinal Chemistry, Biochemical Pharmacology and Life Sciences.

In The Last Decade

K.O. Ellis

20 papers receiving 541 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
K.O. Ellis United States 9 343 201 93 86 57 20 616
A. T. Milhorat United States 16 588 1.7× 171 0.9× 178 1.9× 113 1.3× 66 1.2× 42 902
Brian M. Keyser United States 14 386 1.1× 165 0.8× 63 0.7× 76 0.9× 31 0.5× 36 710
Noriyoshi Teramoto Japan 17 564 1.6× 216 1.1× 188 2.0× 118 1.4× 45 0.8× 67 898
Ella Mohme‐Lundholm Sweden 15 269 0.8× 80 0.4× 152 1.6× 273 3.2× 42 0.7× 43 771
Werner De Potter Belgium 14 329 1.0× 234 1.2× 33 0.4× 50 0.6× 42 0.7× 45 553
Ying‐Ming Liou Taiwan 17 246 0.7× 125 0.6× 150 1.6× 73 0.8× 8 0.1× 51 735
Irwin A. Brody United States 14 309 0.9× 129 0.6× 57 0.6× 81 0.9× 70 1.2× 33 655
Bernd Koidl Austria 19 398 1.2× 234 1.2× 490 5.3× 95 1.1× 60 1.1× 46 930
P Bois Canada 14 337 1.0× 74 0.4× 242 2.6× 89 1.0× 18 0.3× 58 848
Stanislav Berjukow Austria 15 761 2.2× 493 2.5× 433 4.7× 36 0.4× 11 0.2× 21 902

Countries citing papers authored by K.O. Ellis

Since Specialization
Citations

This map shows the geographic impact of K.O. Ellis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K.O. Ellis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K.O. Ellis more than expected).

Fields of papers citing papers by K.O. Ellis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K.O. Ellis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K.O. Ellis. The network helps show where K.O. Ellis may publish in the future.

Co-authorship network of co-authors of K.O. Ellis

This figure shows the co-authorship network connecting the top 25 collaborators of K.O. Ellis. A scholar is included among the top collaborators of K.O. Ellis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K.O. Ellis. K.O. Ellis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Roberts, Richard, Stephanie Allen, Holly Henderson, et al.. (2013). Distinct mechanisms of relaxation to bioactive components from chamomile species in porcine isolated blood vessels. Toxicology and Applied Pharmacology. 272(3). 797–805. 24 indexed citations
2.
Milner, Richard, et al.. (2009). Interaction of Platelet-Rich Concentrate With Bone Graft Materials: An In Vitro Study. Journal of Orthopaedic Trauma. 23(3). 195–200. 8 indexed citations
3.
4.
White, Robert L., et al.. (1987). 1-[[[5-(Substituted phenyl)-2-oxazolyl]methylene]amino]-2,4-imidazolidinediones, a new class of skeletal muscle relaxants. Journal of Medicinal Chemistry. 30(2). 263–266. 17 indexed citations
5.
Pong, S.F., et al.. (1982). Effects of subacute oral administration of captopril (SQ 14,225) on the renin-angiotensin system in spontaneously hypertensive rats. Journal of Pharmacy and Pharmacology. 34(3). 186–187. 1 indexed citations
6.
Ellis, K.O., et al.. (1981). Synthesis and Skeletal Muscle Relaxant Activity of 3- (aminoacyl)-1-[[[5- (substituted phenyl)-2- Furanyl]methylene]amino]-2, 4-imidazolidinediones. Journal of Pharmaceutical Sciences. 70(9). 1088–1090. 1 indexed citations
7.
Ellis, K.O., et al.. (1981). Inhibition of prostaglandin synthetase by F-776, 5-(4-chlorophenyl)-β-hydroxy-2-furanpropanoic acid, a new anti-inflammatory/analgesic compound. Biochemical Pharmacology. 30(21). 3008–3009. 3 indexed citations
8.
Ellis, K.O., et al.. (1980). Pharmacology of 1-(3,4-dichlorobenzyl)-3,4,5,6-tetrahydro-2(1H)-pyrimidone, a novel antidepressant compound with antianxiety activity. Journal of Pharmaceutical Sciences. 69(10). 1198–1202. 2 indexed citations
9.
Ellis, K.O., et al.. (1980). 1-(substituted benzyl)-3,4,5,6-tetrahydro-2(1H)-pyrimidones: A series with stimulant and depressant activities. Journal of Pharmaceutical Sciences. 69(10). 1194–1198. 1 indexed citations
10.
Ellis, K.O., et al.. (1980). Synthesis and Skeletal Muscle Relaxant Activity of Quaternary Ammonium Salts of Dantrolene and Clodanolene. Journal of Pharmaceutical Sciences. 69(3). 327–331. 8 indexed citations
11.
Ellis, K.O., et al.. (1978). Synthesis and comparative skeletal muscle relaxant activity of some 2,4-imidazolidinediones and their corresponding 5-hydroxy-2,4-imidazolidinediones. Journal of Medicinal Chemistry. 21(1). 127–130. 1 indexed citations
12.
Ellis, K.O., et al.. (1978). Muscle relaxant properties of the identified metabolites of dantrolene. Naunyn-Schmiedeberg s Archives of Pharmacology. 301(3). 237–240. 17 indexed citations
13.
Ellis, K.O., et al.. (1976). A comparison of skeletal, cardiac, and smooth muscle actions of dantrolene sodium--a skeletal muscle relaxant.. PubMed. 224(1). 118–32. 38 indexed citations
14.
Ellis, K.O., et al.. (1976). Effects of Intravenous Dantrolene Sodium on Respiratory and Cardiovascular Functions. Journal of Pharmaceutical Sciences. 65(9). 1359–1364. 20 indexed citations
15.
Schwan, Thomas J. & K.O. Ellis. (1975). Positional Isomer of the Muscle Relaxant Dantrolene. Journal of Pharmaceutical Sciences. 64(6). 1047–1047. 4 indexed citations
16.
Schwan, Thomas J. & K.O. Ellis. (1975). 5‐Chloro‐2‐Pyrimidinyl Analog of Dantrolene. Journal of Pharmaceutical Sciences. 64(2). 337–338. 1 indexed citations
17.
Ellis, K.O. & S. H. Bryant. (1973). Aconitine-induced repetitive firing in frog skeletal muscle and the effect on cable properties. Life Sciences. 13(11). 1607–1622. 5 indexed citations
18.
Ellis, K.O., et al.. (1973). Dantrolene, a Direct Acting Skeletal Muscle Relaxant. Journal of Pharmaceutical Sciences. 62(6). 948–951. 67 indexed citations
19.
Ellis, K.O. & S. H. Bryant. (1972). Excitation-contraction uncoupling in skeletal muscle by dantrolene sodium. Naunyn-Schmiedeberg s Archives of Pharmacology. 274(1). 107–109. 136 indexed citations
20.
Ellis, K.O. & John F. Carpenter. (1972). Studies on the mechanism of action of dantrolene sodium. Naunyn-Schmiedeberg s Archives of Pharmacology. 275(1). 83–94. 231 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A. T. Milhorat Breakdown of academic impact, for papers by Brian M. Keyser Breakdown of academic impact, for papers by Noriyoshi Teramoto Breakdown of academic impact, for papers by Ella Mohme‐Lundholm Breakdown of academic impact, for papers by Werner De Potter Breakdown of academic impact, for papers by Ying‐Ming Liou Breakdown of academic impact, for papers by Irwin A. Brody Breakdown of academic impact, for papers by Bernd Koidl Breakdown of academic impact, for papers by P Bois Breakdown of academic impact, for papers by Stanislav Berjukow
Rankless by CCL
2026